Xencor reported $598K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Arrowhead Research ARWR:US $ 198K 0
AstraZeneca AZN:LN 387M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Epizyme EPZM:US $ 0.02M 0.01M
GlaxoSmithKline GSK:LN 1347M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Novartis NOVN:VX SF 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Xencor XNCR:US $ 0.6M 0M